STOCK TITAN

Assertio Holdings, Inc. - $ASRT STOCK NEWS

Welcome to our dedicated page for Assertio Holdings news (Ticker: $ASRT), a resource for investors and traders seeking the latest updates and insights on Assertio Holdings stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Assertio Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Assertio Holdings's position in the market.

Rhea-AI Summary
Assertio Holdings, Inc. will report its first quarter 2024 financial results on May 6, 2024. The Company, a pharmaceutical firm, will conduct a live webcast of the earnings conference call at 4:30 p.m. Eastern Time on the same day.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.3%
Tags
conferences earnings
-
Rhea-AI Summary
Assertio Holdings, Inc. appoints Sigurd Kirk, a seasoned pharmaceutical executive, to its board of directors, bringing extensive experience in business development and financial management. Kirk's background includes executive roles at Allergan plc and Barr Pharmaceuticals, enhancing Assertio's strategic growth initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.61%
Tags
management
-
Rhea-AI Summary
Assertio Holdings, Inc. announces CFO's participation at LD Micro Invitational XIV Conference on April 9, 2024 in NYC. Investors can request meetings and access presentation information online.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.01%
Tags
conferences
Rhea-AI Summary
Assertio Holdings, Inc. reported fourth-quarter net product sales of $32.5 million and cash flow from operations of $5.7 million. The company provided a 2024 full-year outlook for net product sales of $110 to $125 million and adjusted EBITDA of $20 to $30 million. Despite a decline in net product sales and gross profits, Assertio remains focused on growth strategies, cost optimization, and new business development opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.06%
Tags
-
Rhea-AI Summary
Assertio Holdings, Inc. announced the release of its fourth quarter and full year 2023 financial results on March 11, 2024. The company specializes in safe and effective therapies for patients. A live webcast of the earnings conference call will be hosted by Assertio's management at 4:30 p.m. Eastern Time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
-
News
Rhea-AI Summary
Investors who suffered losses exceeding $25,000 in Assertio (ASRT) between March 9, 2023, and November 8, 2023, are encouraged to contact Faruqi & Faruqi for potential claims. The investigation alleges false statements by Assertio executives, impacting profitability and stock performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
none
Rhea-AI Summary
Assertio Holdings, Inc. (ASRT) granted 16,498 restricted stock units and 18,654 stock options to two newly-hired employees, with the options having an exercise price of $1.14 per share and vesting equally annually over three years.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Assertio Holdings, Inc. (NASDAQ: ASRT) announces the stepping down of CEO Dan Peisert and the appointment of Heather Mason as interim CEO. Heather Mason, a current board member with extensive pharmaceutical and healthcare industry experience, will lead the company as it conducts a search for a permanent chief executive.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.4%
Tags
management
-
Rhea-AI Summary
Assertio Holdings, Inc. (NASDAQ: ASRT) announced the appointment of Sravan Emany, the Chief Financial Officer of Ironwood Pharmaceuticals, to its Board of Directors, expanding the board to seven seats. Mr. Emany's extensive experience in pharmaceuticals and financial leadership is expected to bring depth to the board and contribute to the company's growth and transformation, delivering meaningful shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
management
Rhea-AI Summary
ASRT: Assertio Holdings, Inc. announces financial results for Q3 2023, reporting a cash balance of $76.9 million and the acquisition of Spectrum. The company experienced a net loss of $279.5 million, with net product sales increasing to $35.1 million. Rolvedon net product sales were $7.1 million for the two months following the acquisition. The addition of Rolvedon diversifies and extends the company's portfolio duration, but the loss of Indocin exclusivity and Rolvedon results below expectations drove significant charges to net income.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-43.19%
Tags
Assertio Holdings, Inc.

Nasdaq:ASRT

ASRT Rankings

ASRT Stock Data

97.98M
79.95M
1.63%
50.36%
10.92%
Medicinal and Botanical Manufacturing
Manufacturing
Link
United States of America
LAKE FOREST

About ASRT

assertio reflects an aspirational mindset that is forward thinking, energetic, and entrepreneurial in spirit. ticker symbol: asrt